title: [The contribution of protein kinase C and Rho-kinase to the control of the receptor-dependent artery contraction decreases with age independently of sympathetic innervation].
abstract: The age-related dynamics of the activity of signalling pathways coupled to alpha1-adrenergic receptors and their dependence on the sympathetic innervation of arterial smooth muscle have been studied. The effects of the protein kinase C inhibitor (GF109203X, 10(-6) M) and the Rho-kinase inhibitor (Y27632, 10(-5) M) on the isometric contraction of the rat saphenous artery, induced by the alpha1-adrenoceptor agonist methoxamine, were examined. It was shown that the sensitivity to methoxamine of arteries from 2-week-old rats that are partially innervated was reduced as compared to adults, but the effects of both inhibitors were more prominent. The denervation induced by the excision of sympathetic ganglia increased the arterial sensitivity to methoxamine but was not accompanied by changes in sensitivity to the inhibitors. Therefore, the postnatal development of the arterial smooth muscle is characterized by a decrease in the contribution of protein kinase C and Rho-kinase to the regulation of contraction; however, these changes do not correlate with changes in the sensitivity of arteries to methoxamine and development of sympathetic innervation.
authors.forename: S V
authors.initials: SV
authors.lastname: Mochalov
authors.forename: V U
authors.initials: VU
authors.lastname: Kalenchuk
authors.forename: D K
authors.initials: DK
authors.lastname: Gaĭnullina
authors.forename: A V
authors.initials: AV
authors.lastname: Vorotnikov
authors.forename: O S
authors.initials: OS
authors.lastname: Tarasova
mesh_terms: D058646:Adrenergic alpha-1 Receptor Agonists; D000367:Age Factors; D000577:Amides / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000254:growth & development / Q000294:innervation / Q000502:physiology*; D015171:Ganglionectomy; D007211:Indoles / Q000494:pharmacology; D007537:Isometric Contraction; D008301:Maleimides / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D018482:Muscle, Skeletal / Q000098:blood supply; D009131:Muscle, Smooth, Vascular / Q000254:growth & development / Q000294:innervation / Q000502:physiology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000254:growth & development / Q000502:physiology*; D054460:rho-Associated Kinases / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D058646:Adrenergic alpha-1 Receptor Agonists; D000577:Amides; D007211:Indoles; D008301:Maleimides; D011725:Pyridines; D018340:Receptors, Adrenergic, alpha-1; C108830:Y 27632; D054460:rho-Associated Kinases; D011493:Protein Kinase C; D008729:Methoxamine; C070515:bisindolylmaleimide I